SciSparc Ltd. (SPRC) director amends Form 3, details 3,649-share stake

Rhea-AI Filing Summary

SciSparc Ltd. director Lior Vider filed an amended initial ownership report updating his beneficial holdings. The amendment states that he beneficially owns 3,649 Ordinary Shares, which include (i) 3,333 Ordinary Shares issuable upon vesting of RSUs in quarterly installments of 417 shares through December 18, 2027, and (ii) 316 Ordinary Shares issuable upon vesting of RSUs in equal quarterly installments of 40 shares through June 20, 2026. The amendment also restates Table II to show a stock option directly held covering 1 underlying Ordinary Share at an exercise price of 31649.0000, exercisable from January 3, 2022 and expiring on January 3, 2028.

Filing Explained

The amendment reports a director’s RSU-linked beneficial ownership and one option; it does not disclose completed issuance, exercise, or sale.

The July 13, 2026 amendment updates the director’s March 18, 2026 initial ownership statement, reporting 3,649 ordinary shares as directly held beneficial ownership and a separate option for 1 ordinary share.

The filing clarifies the filer’s reported ownership and rights: the RSU shares are described as issuable upon vesting, while the option is a right to buy, so neither item is placed at completed issuance or exercise.

The 3,649-share total consists of 3,333 RSU shares vesting quarterly through December 18, 2027 and 316 RSU shares vesting quarterly through June 20, 2026; each RSU represents the right to receive one ordinary share.

The separate stock option is exercisable from January 3, 2022 through January 3, 2028, covers 1 ordinary share, and lists an exercise price of $31,649.

Sources and calculations

• SciSparc Ltd. Form 3/A amended initial statement of beneficial ownership (2026-07-13)

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Vider Lior

Role Director

Type	Security	Shares	Price	Value
holding	Stock option (right to buy) F2	--	--	--
holding	Ordinary Shares F1	--	--	--

Holdings After Transaction: Stock option (right to buy) — 1 shares (Direct); Ordinary Shares — 3,649 shares (Direct)

Footnotes (2)

1. F1. This Form is filed solely as an amendment to the Form 3 filed on March 18, 2026. This amendment amends the total number of securities beneficially owned by the reporting person in Table I, and amends and restates the first footnote in Table I as follows: "Includes (i) 3,333 ordinary shares, no par value per share, of the Issuer (the "Ordinary Shares") issuable upon the vesting of restricted share units ("RSUs") in quarterly installments of 417 Ordinary Shares through December 18, 2027; and (ii) 316 Ordinary Shares issuable upon the vesting of RSUs in equal quarterly installments of 40 Ordinary Shares through June 20, 2026. Each RSU represents the right to receive one Ordinary Share."
2. F2. This amendment amends and restates Table II of the initial Form 3, as provided herein. No amendment is made hereby to any other footnotes of the initial Form 3.

Key Figures

Beneficially owned Ordinary Shares: 3,649 shares RSUs underlying Ordinary Shares (main grant): 3,333 shares RSUs underlying Ordinary Shares (additional grant): 316 shares +2 more

5 metrics

Beneficially owned Ordinary Shares 3,649 shares Total Ordinary Shares beneficially owned by Lior Vider after amendment

RSUs underlying Ordinary Shares (main grant) 3,333 shares Ordinary Shares issuable upon RSU vesting in quarterly 417-share installments through December 18, 2027

RSUs underlying Ordinary Shares (additional grant) 316 shares Ordinary Shares issuable upon RSU vesting in quarterly 40-share installments through June 20, 2026

Stock option exercise price 31649.0000 Exercise price for option on 1 underlying Ordinary Share expiring January 3, 2028

Underlying shares for stock option 1 share Underlying Ordinary Share covered by the reported stock option position

Key Terms

beneficially owned, restricted share units ("RSUs"), stock option (right to buy), Table I, +1 more

5 terms

beneficially owned financial

"amends the total number of securities beneficially owned by the reporting person in Table I"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

restricted share units ("RSUs") financial

"Includes (i) 3,333 ordinary shares... issuable upon the vesting of restricted share units ("RSUs")"

stock option (right to buy) financial

"Stock option (right to buy) ... underlying security title Ordinary Shares"

Table I regulatory

"amends the total number of securities beneficially owned by the reporting person in Table I"

Table II regulatory

"This amendment amends and restates Table II of the initial Form 3"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Available on EDGAR 07/13/2026 - 07:09 AM Accepted by SEC EDGAR 07/13/2026 - 07:02 AM Learn about SEC filing dates

FAQ

What does SciSparc (SPRC) director Lior Vider report in this amended Form 3?

Lior Vider reports beneficial ownership of 3,649 Ordinary Shares of SciSparc Ltd. This total includes shares underlying restricted share units (RSUs) that vest in quarterly installments through 2026 and 2027, plus a directly held stock option.

How many SciSparc (SPRC) RSU-based shares does Lior Vider report as beneficially owned?

He reports RSUs for 3,333 Ordinary Shares vesting in quarterly installments of 417 shares through December 18, 2027, and RSUs for 316 Ordinary Shares vesting in quarterly installments of 40 shares through June 20, 2026, each RSU representing one Ordinary Share.

What is the total number of SciSparc (SPRC) Ordinary Shares beneficially owned by Lior Vider?

The amended report shows 3,649 Ordinary Shares beneficially owned. This figure includes both currently held shares and unvested RSUs that are scheduled to vest over time, each convertible into one Ordinary Share upon vesting.

What stock option position does Lior Vider disclose in SciSparc (SPRC) in this amendment?

He discloses a directly held stock option covering 1 underlying Ordinary Share with an exercise price of 31649.0000. The option became exercisable on January 3, 2022 and has an expiration date of January 3, 2028 as shown in Table II.

What is the purpose of this amended Form 3 for SciSparc (SPRC)?

The amendment is filed to correct and restate the initial Form 3 filed on March 18, 2026. It updates the total number of securities beneficially owned in Table I and fully amends and restates Table II, without changing other original footnotes.

How do the RSUs reported for SciSparc (SPRC) vest for Lior Vider?

RSUs for 3,333 shares vest in quarterly installments of 417 shares through December 18, 2027. RSUs for 316 shares vest in equal quarterly installments of 40 shares through June 20, 2026, each RSU converting into one Ordinary Share at vesting.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Vider Lior

(Last) (First) (Middle)

20 RAUL WALLENBERG STREET

TOWER A, TEL AVIV, ISRAEL

(Street)

TEL AVIV 6971916

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
SciSparc Ltd. [ SPRC ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)
03/18/2026

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	3,649(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock option (right to buy)	01/03/2022	01/03/2028	Ordinary Shares	1(2)	$31,649	D

Explanation of Responses:

1. This Form is filed solely as an amendment to the Form 3 filed on March 18, 2026. This amendment amends the total number of securities beneficially owned by the reporting person in Table I, and amends and restates the first footnote in Table I as follows: "Includes (i) 3,333 ordinary shares, no par value per share, of the Issuer (the "Ordinary Shares") issuable upon the vesting of restricted share units ("RSUs") in quarterly installments of 417 Ordinary Shares through December 18, 2027; and (ii) 316 Ordinary Shares issuable upon the vesting of RSUs in equal quarterly installments of 40 Ordinary Shares through June 20, 2026. Each RSU represents the right to receive one Ordinary Share."

2. This amendment amends and restates Table II of the initial Form 3, as provided herein. No amendment is made hereby to any other footnotes of the initial Form 3.

	/s/ Lior Vider	07/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)